Understanding EMPA-REG OUTCOME
- PMID: 26590679
- DOI: 10.1016/S2213-8587(15)00424-6
Understanding EMPA-REG OUTCOME
Erratum in
- Lancet Diabetes Endocrinol. Lancet Diabetes Endocrinol 2016 Feb;4(2):e2
Comment on
-
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17. N Engl J Med. 2015. PMID: 26378978 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical